Figure 1
Pregabalin Capsule
Product Images NDC 80425-0147
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 10
Figure 11
Figure 12
Figure 2
Figure 3
Figure 4
This is a chart showing the percentage of patients improved in pain from baseline after taking Pregabalin 200mg three times per day, Pregabalin 100mg three times per day, and Placebo. There are no specific details or explanations included in the text.*
Figure 5
Figure 6
Figure 7
Figure 9
This graph displays the percentage of patients who experienced improvement in their pain levels from baseline while taking different doses of Pregabalin versus a placebo. The x-axis indicates the different dose levels and the y-axis displays the percentage of patients who experienced improvement. The results show that higher doses of Pregabalin (600mg and 450mg) resulted in more significant improvement in patients' pain levels compared to lower doses (300mg) and the placebo.*
Pregabalin 75mg Cap Qty 60 80425 0147
This appears to be a label from a pharmaceutical product with the name "PRECABALLN" and a strength of "75\ CAP 460". The manufacturer or packager is listed as "AAdvancedx’i X". There is also a temperature recommendation of "20 2°C" and a code number of "B0PR75622".*
Pregabalin 75mg Cap Qty 90 80425 0147
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
